BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trovato M, Sartorius R, D'Apice L, Manco R, De Berardinis P. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies. Front Immunol 2020;11:2130. [PMID: 33013898 DOI: 10.3389/fimmu.2020.02130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Zheng W, Sun Y, Li H, Zhao H, Zhan Y, Gao Y, Hu Y, Li P, Lin YF, Chen H, Meng H, Yang C, Fang Q, Yuan J, Jiang Y, Liu S, Cai Y, Zou H. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey. Hum Vaccin Immunother 2021;:1-11. [PMID: 34890297 DOI: 10.1080/21645515.2021.1996152] [Reference Citation Analysis]
2 Suchowiecki K, Reid SP, Simon GL, Firestein GS, Chang A. Persistent Joint Pain Following Arthropod Virus Infections. Curr Rheumatol Rep 2021;23:26. [PMID: 33847834 DOI: 10.1007/s11926-021-00987-y] [Reference Citation Analysis]
3 Crum T, Mooney K, Tiwari BR. Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases. F1000Res 2021;10:652. [PMID: 35035888 DOI: 10.12688/f1000research.51160.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Blahove MR, Carter JR. Flavivirus Persistence in Wildlife Populations. Viruses 2021;13:2099. [PMID: 34696529 DOI: 10.3390/v13102099] [Reference Citation Analysis]
5 Cakir M, Obernier K, Forget A, Krogan NJ. Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches. mSystems 2021;6:e0038821. [PMID: 34519533 DOI: 10.1128/mSystems.00388-21] [Reference Citation Analysis]
6 Herrera-Bravo J, Farías JG, Contreras FP, Herrera-Belén L, Norambuena JA, Beltrán JF. VirVACPRED: A Web Server for Prediction of Protective Viral Antigens. Int J Pept Res Ther 2022;28:35. [PMID: 34934411 DOI: 10.1007/s10989-021-10345-2] [Reference Citation Analysis]
7 Sánchez-Ramón S, Fernández-Paredes L, Saz-Leal P, Diez-Rivero CM, Ochoa-Grullón J, Morado C, Macarrón P, Martínez C, Villaverde V, de la Peña AR, Conejero L, Hernández-Llano K, Cordero G, Fernández-Arquero M, Gutierrez BF, Candelas G. Sublingual Bacterial Vaccination Reduces Recurrent Infections in Patients With Autoimmune Diseases Under Immunosuppressant Treatment. Front Immunol 2021;12:675735. [PMID: 34149711 DOI: 10.3389/fimmu.2021.675735] [Reference Citation Analysis]
8 Celis-Giraldo CT, López-Abán J, Muro A, Patarroyo MA, Manzano-Román R. Nanovaccines against Animal Pathogens: The Latest Findings. Vaccines (Basel) 2021;9:988. [PMID: 34579225 DOI: 10.3390/vaccines9090988] [Reference Citation Analysis]
9 Cave R, Cole J, Mkrtchyan HV. Surveillance and prevalence of antimicrobial resistant bacteria from public settings within urban built environments: Challenges and opportunities for hygiene and infection control. Environ Int 2021;157:106836. [PMID: 34479136 DOI: 10.1016/j.envint.2021.106836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Poveda-Cuevas SA, Etchebest C, da Silva FLB. Self-association features of NS1 proteins from different flaviviruses. Virus Res 2022;:198838. [PMID: 35662566 DOI: 10.1016/j.virusres.2022.198838] [Reference Citation Analysis]
11 Thakor JC, Dinesh M, Manikandan R, Bindu S, Sahoo M, Sahoo D, Dhawan M, Pandey MK, Tiwari R, Emran TB, Dhama K, Chaicumpa W. Swine coronaviruses (SCoVs) and their emerging threats to swine population, inter-species transmission, exploring the susceptibility of pigs for SARS-CoV-2 and zoonotic concerns. Vet Q 2022;:1-39. [PMID: 35584308 DOI: 10.1080/01652176.2022.2079756] [Reference Citation Analysis]
12 Lefebvre M, Vignier N, Pitard B, Botelho-Nevers E, Wyplosz B, Cohen R, Epaulard O; SPILF Vaccination Prevention group. COVID-19 vaccines: Frequently asked questions and updated answers. Infect Dis Now 2021;51:319-33. [PMID: 33681861 DOI: 10.1016/j.idnow.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Tuells J, Parra-grande M, Santos-calle FJ, Montagud AC, Egoavil CM, García-rivera C, Caballero P, Gabaldón-bravo EM, Rodríguez-diaz JC, Hurtado-sánchez JA. Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA. Vaccines 2022;10:510. [DOI: 10.3390/vaccines10040510] [Reference Citation Analysis]
14 Van Tilbeurgh M, Lemdani K, Beignon AS, Chapon C, Tchitchek N, Cheraitia L, Marcos Lopez E, Pascal Q, Le Grand R, Maisonnasse P, Manet C. Predictive Markers of Immunogenicity and Efficacy for Human Vaccines. Vaccines (Basel) 2021;9:579. [PMID: 34205932 DOI: 10.3390/vaccines9060579] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wu C, Yan J, Wu J, Wu P, Cheng F, Du L, Du Y, Lei S, Lang H. Development, reliability and validity of infectious disease specialist Nurse's Core competence scale. BMC Nurs 2021;20:231. [PMID: 34789255 DOI: 10.1186/s12912-021-00757-2] [Reference Citation Analysis]
16 Knudson CJ, Alves-Peixoto P, Muramatsu H, Stotesbury C, Tang L, Lin PJC, Tam YK, Weissman D, Pardi N, Sigal LJ. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection. Mol Ther 2021;29:2769-81. [PMID: 33992803 DOI: 10.1016/j.ymthe.2021.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mazur-Marzec H, Cegłowska M, Konkel R, Pyrć K. Antiviral Cyanometabolites-A Review. Biomolecules 2021;11:474. [PMID: 33810129 DOI: 10.3390/biom11030474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ling Y, Zhong J, Luo J. Safety and effectiveness of SARS-CoV-2 vaccines: A systematic review and meta-analysis. J Med Virol 2021. [PMID: 34264528 DOI: 10.1002/jmv.27203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Renauld JM, Basch ML. Congenital Deafness and Recent Advances Towards Restoring Hearing Loss. Curr Protoc 2021;1:e76. [PMID: 33780161 DOI: 10.1002/cpz1.76] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Nazary Abrbekoh F, Salimi L, Saghati S, Amini H, Fathi Karkan S, Moharamzadeh K, Sokullu E, Rahbarghazi R. Application of microneedle patches for drug delivery; doorstep to novel therapies. J Tissue Eng 2022;13:204173142210853. [DOI: 10.1177/20417314221085390] [Reference Citation Analysis]
21 Ramamurthy D, Nundalall T, Cingo S, Mungra N, Karaan M, Naran K, Barth S. Recent advances in immunotherapies against infectious diseases. Immunotherapy Advances 2021;1:ltaa007. [DOI: 10.1093/immadv/ltaa007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Soraci L, Lattanzio F, Soraci G, Gambuzza ME, Pulvirenti C, Cozza A, Corsonello A, Luciani F, Rezza G. COVID-19 Vaccines: Current and Future Perspectives. Vaccines 2022;10:608. [DOI: 10.3390/vaccines10040608] [Reference Citation Analysis]